BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10667591)

  • 1. Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.
    Cinti C; Claudio PP; Howard CM; Neri LM; Fu Y; Leoncini L; Tosi GM; Maraldi NM; Giordano A
    Cancer Res; 2000 Jan; 60(2):383-9. PubMed ID: 10667591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.
    Cinti C; Leoncini L; Nyongo A; Ferrari F; Lazzi S; Bellan C; Vatti R; Zamparelli A; Cevenini G; Tosi GM; Claudio PP; Maraldi NM; Tosi P; Giordano A
    Am J Pathol; 2000 Mar; 156(3):751-60. PubMed ID: 10702389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors.
    Masciullo V; Valdivieso P; Amadio G; Santoro A; Angelico G; Sgambato A; Boffo S; Giordano A; Scambia G; Zannoni GF
    Front Med (Lausanne); 2020; 7():596226. PubMed ID: 33262995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.
    Alvi AJ; Hogg R; Rader JS; Kuo MJ; Maher ER; Latif F
    Mol Pathol; 2002 Jun; 55(3):153-5. PubMed ID: 12032225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism.
    Chestukhin A; Litovchick L; Rudich K; DeCaprio JA
    Mol Cell Biol; 2002 Jan; 22(2):453-68. PubMed ID: 11756542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells.
    Alessio N; Bohn W; Rauchberger V; Rizzolio F; Cipollaro M; Rosemann M; Irmler M; Beckers J; Giordano A; Galderisi U
    Cell Mol Life Sci; 2013 May; 70(9):1637-51. PubMed ID: 23370776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma: a review of current and future therapeutic approaches.
    Zhao X; Wu Q; Gong X; Liu J; Ma Y
    Biomed Eng Online; 2021 Mar; 20(1):24. PubMed ID: 33653371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TP73-AS1 down-regulates
    Xia Z; Yang X; Wu S; Feng Z; Qu L; Chen X; Liu L; Ma Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.
    Indovina P; Pentimalli F; Casini N; Vocca I; Giordano A
    Oncotarget; 2015 Jul; 6(20):17873-90. PubMed ID: 26160835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.
    Aquino G; Marra L; Cantile M; De Chiara A; Liguori G; Curcio MP; Sabatino R; Pannone G; Pinto A; Botti G; Franco R
    Infect Agent Cancer; 2013 Sep; 8(1):37. PubMed ID: 24079473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging non-transplant-based strategies in treating pediatric non-Hodgkin's lymphoma.
    Gore L; Trippett TM
    Curr Hematol Malig Rep; 2010 Oct; 5(4):177-84. PubMed ID: 20640605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual loss of rb1 and Trp53 in the adrenal medulla leads to spontaneous pheochromocytoma.
    Tonks ID; Mould AW; Schroder WA; Cotterill A; Hayward NK; Walker GJ; Kay GF
    Neoplasia; 2010 Mar; 12(3):235-43. PubMed ID: 20234817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda.
    Kalungi S; Steine SJ; Wabinga H; Bostad L; Molven A
    BMC Clin Pathol; 2009 Aug; 9():6. PubMed ID: 19691827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy.
    Moparthi SB; Bergman V; Adell G; Thorstensson S; Sun XF
    Int J Colorectal Dis; 2009 Nov; 24(11):1303-10. PubMed ID: 19597825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in Burkitt's tumor formation.
    Campanero MR
    Clin Transl Oncol; 2008 May; 10(5):250-5. PubMed ID: 18490240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization sequences in cytomegalovirus capsid assembly proteins (UL80 proteins) are required for virus production: inactivating NLS1, NLS2, or both affects replication to strikingly different extents.
    Nguyen NL; Loveland AN; Gibson W
    J Virol; 2008 Jun; 82(11):5381-9. PubMed ID: 18353959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.
    Genovese NJ; Banerjee NS; Broker TR; Chow LT
    J Virol; 2008 May; 82(10):4862-73. PubMed ID: 18321970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma: from molecular pathology to therapy.
    Rossi A; Caracciolo V; Russo G; Reiss K; Giordano A
    Clin Cancer Res; 2008 Feb; 14(4):971-6. PubMed ID: 18281528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia.
    Shadeo A; Chari R; Lonergan KM; Pusic A; Miller D; Ehlen T; Van Niekerk D; Matisic J; Richards-Kortum R; Follen M; Guillaud M; Lam WL; MacAulay C
    BMC Genomics; 2008 Feb; 9():64. PubMed ID: 18248679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and Burkitt lymphoma.
    Brady G; MacArthur GJ; Farrell PJ
    J Clin Pathol; 2007 Dec; 60(12):1397-402. PubMed ID: 18042696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.